Serologic surveillance for west nile virus and other flaviviruses in febrile patients, encephalitic patients, and asymptomatic blood donors in Northern Mexico

Vector-Borne and Zoonotic Diseases

Volumn 10, Issue 2, 2010, Pages 151-157

  Rodríguez, María De Lourdes Garza ^a,b   Rodríguez Rodriguez, Diana R ^a   Blitvich, Bradley J ^c   López, Miguel Á Reyes ^b   Fernández Salas, Ildefonso ^a   Jimenez, Javier Ramos ^a   Farfán Ale, José A ^d   Tamez, Rogelio Cazares ^a   Longoria, César Martinez ^a   Aguilar, Maria I Tavitas ^e   Rivas Estilla, Ana Maria ^a  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c IOWA STATE UNIVERSITY   (United States)

^d UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

^e Diagnostic Reference Laboratory from Federal Secretariat of Health   (Mexico)

Author keywords

Blood donor; Dengue virus; Flavivirus; Human; Mexico; Surveillance; West Nile virus

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NEUTRALIZING ANTIBODY;

ADULT; ANTIBODY SCREENING; ARTICLE; BLOOD DONOR; DENGUE VIRUS; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; FLAVIVIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; PRIORITY JOURNAL; SEROLOGY; SEROPREVALENCE; VIRUS CULTURE; WEST NILE FLAVIVIRUS;

DENGUE VIRUS; FLAVIVIRUS; WEST NILE VIRUS;

EID: 77950586422     PISSN: 15303667     EISSN: None     Source Type: Journal    
DOI: 10.1089/vbz.2008.0203     Document Type: Article

References (39)

1. Beaty, B, Calisher, CH, Shope, RE. Arboviruses. In: Lennette, EH. ed. Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections, 7th ed., 1995:189-212.
2. Blitvich, BJ. Transmission dynamics and changing epidemiology of West Nile virus. Anim Health Res Rev 2008; 9:71-86.
3. Blitvich, BJ, Fernandez-Salas, I, Contreras-Cordero, JF, Marlenee, NL, et al. Serologic evidence of West Nile virus infection in horses, Coahuila State, Mexico. Emerg Infect Dis 2003; 9:853-856.
4. Brunkard, JM, Robles Lopez, JL, Ramirez, J, Cifuentes, E, et al. Dengue fever seroprevalence and risk factors, Texas-Mexico border, 2004. Emerg Infect Dis 2007; 13:1477-1483.
5. Burke, D, Monath, T. Flaviviruses. In: Knipe, D, Howley, P, eds. Fields Virology, fourth edition. Philadelphia: Lippincott Williams and Wilkins, 2001:1043-1126.
6. Calisher, CH, Karabatsos, N, Dalrymple, JM, Shope, RE, et al. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol 1989; 70 (Pt 1):37-43.
7. CDC 2009. The U.S. National Case Definition for West Nile virus. http:==www.cdc.gov=epo=dphsi=casedef=arboviral-current .htm. Accessed on January 24, 2009.
8. Chappell, WA, Sasso, DR, Toole, RF, Monath, TP. Labile serum factor and its effect on arbovirus neutralization. Appl Microbiol 1971; 21:79-83.
9. Estrada-Franco, JG, Navarro-Lopez, R, Beasley, DW, Coffey, L, et al. West Nile virus in Mexico: evidence of widespread circulation since July 2002. Emerg Infect Dis 2003; 9:1604-1607.
10. Fernandez-Salas, I, Contreras-Cordero, JF, Blitvich, BJ, Gonzalez-Rojas, JI, et al. Serologic evidence of West Nile Virus infection in birds, Tamaulipas State, Mexico. Vector Borne Zoonot Dis 2003; 3:209-213.
11. Goverdhan, MK, Kulkarni, AB, Gupta, AK, Tupe, CD, et al. Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques. Acta Virol 1992; 36:277-283.
12. Gubler, DJ. Epidemic dengue=dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 2002; 10:100-103.
13. Gubler, DJ. Dengue=dengue haemorrhagic fever: history and current status. Novartis Found Symp 2006; 277:3-16; discussion 16-22, 71-13, 251-253.
14. Hayes, EB, Gubler, DJ. West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annu Rev Med 2006; 57:181-194.
15. Hayes, EB, Sejvar, JJ, Zaki, SR, Lanciotti, RS, et al. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis 2005; 11:1174-1179.
16. Hogrefe, WR, Moore, R, Lape-Nixon, M, Wagner, M, et al. Performance of immunoglobulin G (IgG) and IgM enzymelinked immunosorbent assays using a West Nile virus recombinant antigen (preM=E) for detection of West Nile virus- and other flavivirus-specific antibodies. J Clin Microbiol 2004; 42:4641-4648.
17. Ilkal, MA, Prasanna, Y, Jacob, PG, Geevarghese, G, et al. Experimental studies on the susceptibility of domestic pigs to West Nile virus followed by Japanese encephalitis virus infection and vice versa. Acta Virol 1994; 38:157-161.
18. Komar, N, Clark, GG. West Nile virus activity in Latin America and the Caribbean. Rev Panam Salud Publica 2006; 19:112-117.
19. Kramer, LD, Styer, LM, Ebel, GD. A global perspective on the epidemiology of West Nile Virus. Annu Rev Entomol 2008; 53:61-81.
20. Kyle, JL, Harris, E. Global spread and persistence of dengue. Annu Rev Microbiol 2008; 62:71-92.
21. Lanciotti, RS, Roehrig, JT, Deubel, V, Smith, J, et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 1999; 286:2333-2337.
22. Loeb, M, Elliott, SJ, Gibson, B, Fearon, M, et al. Protective behavior and West Nile virus risk. Emerg Infect Dis 2005; 11:1433-1436.
23. Lorono-Pino, MA, Blitvich, BJ, Farfan-Ale, JA, Puerto, FI, et al. Serologic evidence of West Nile virus infection in horses, Yucatan State, Mexico. Emerg Infect Dis 2003; 9:857-859.
24. Malan, AK, Martins, TB, Hill, HR, Litwin, CM. Evaluations of commercial West Nile virus immunoglobulin G (IgG) and IgM enzyme immunoassays show the value of continuous validation. J Clin Microbiol 2004; 42:727-733.
25. Martin, DA, Muth, DA, Brown, T, Johnson, AJ, et al. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol 2000; 38:1823-1826.
26. Martin, DA, Biggerstaff, BJ, Allen, B, Johnson, AJ, et al. Use of immunoglobulin m cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States. Clin Diagn Lab Immunol 2002; 9:544-549.
27. Mostashari, F, Bunning, ML, Kitsutani, PT, Singer, DA, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001; 358:261-264.
28. Murphy, TD, Grandpre, J, Novick, SL, Seys, SA, et al. West Nile virus infection among health-fair participants, Wyoming 2003: assessment of symptoms and risk factors. Vector Borne Zoonot Dis 2005; 5:246-251.
29. Nash, D, Mostashari, F, Fine, A, Miller, J, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001; 344:1807-1814. (Pubitemid 32538693)
30. Price, WH, Thind, IS. Protection against West Nile virus induced by a previous injection with dengue virus. Am J Epidemiol 1971; 94:596-607.
31. Ramos, MM, Mohammed, H, Zielinski-Gutierrez, E, Hayden, MH, et al. Epidemic dengue and dengue hemorrhagic fever at the Texas-Mexico border: results of a household-based seroepidemiologic survey, December 2005. Am J Trop Med Hyg 2008; 78:364-369.
32. Roehrig, JT, Nash, D, Maldin, B, Labowitz, A, et al. Persistence of virus-reactive serum immunoglobulin m antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis 2003; 9:376-379.
33. Sanchez-Guerrero, SA, Romero-Estrella, S, Rodriguez-Ruiz, A, Infante-Ramirez, L, et al. Detection of West Nile virus in the Mexican blood supply. Transfusion 2006; 46:111-117.
34. Sejvar, JJ, Marfin, AA. Manifestations of West Nile neuroinvasive disease. Rev Med Virol 2006; 16:209-224.
35. Smithburn, KC, Hughes, TP, Burke, AW, Paul, JH. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med Hyg 1940; 20:471-492.
36. Tardei, G, Ruta, S, Chitu, V, Rossi, C, et al. Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile virus infection. J Clin Microbiol 2000; 38:2232-2239.
37. Tesh, RB, Travassos da Rosa, AP, Guzman, H, Araujo, TP, et al. Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis. Emerg Infect Dis 2002; 8:245-251.
38. Thomas, SJ, Strickman, D, Vaughn, DW. Dengue epidemiology: virus epidemiology, ecology, and emergence. Adv Virus Res 2003; 61:235-289.
39. Tilley, PA, Walle, R, Chow, A, Jayaraman, GC, et al. Clinical utility of commercial enzyme immunoassays during the inaugural season of West Nile virus activity, Alberta, Canada. J Clin Microbiol 2005; 43:4691-4695.